Search Results

There are 3352138 results for: content related to: Cumulative Experience with High-Dose Intravenous Cyclophosphamide and ACTH Therapy in Chronic Progressive Multiple Sclerosis

  1. Therapeutic apheresis in neurological disorders

    Journal of Clinical Apheresis

    Volume 15, Issue 1-2, 2000, Pages: 74–128, Robert Weinstein

    Version of Record online : 29 MAR 2000, DOI: 10.1002/(SICI)1098-1101(2000)15:1/2<74::AID-JCA6>3.0.CO;2-O

  2. Immunotherapy of multiple sclerosis

    Annals of Neurology

    Volume 23, Issue 3, March 1988, Pages: 211–222, Dr. Howard L. Weiner and David A. Hafler

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410230302

  3. SUBJECT INDEX

    Annals of the New York Academy of Sciences

    Volume 634, Issue 1, December 1992, Pages: 181–577,

    Version of Record online : 23 DEC 2015, DOI: 10.1111/j.1749-6632.1992.tb00009.x

  4. Plasmapheresis in chronic progressive multiple sclerosis: Pro

    Journal of Clinical Apheresis

    Volume 6, Issue 4, 1991, Pages: 207–210, Michael P. McQuillen

    Version of Record online : 14 NOV 2006, DOI: 10.1002/jca.2920060407

  5. Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis

    Annals of Neurology

    Volume 25, Issue 2, February 1989, Pages: 172–178, Dr. John L. Trotter, David B. Clifford, Jane E. McLnnis, Rogers C. Griffeth, Kathy A. Bruns, Monica S. Perlmutter, Charles B. Anderson, Kelly G. Collins, Geneva Banks and Byron C. Hicks

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410250211

  6. T Cells in Multiple Sclerosis and Inflammatory Central Nervous System Diseases

    Immunological Reviews

    Volume 100, Issue 1, December 1987, Pages: 307–332, David A. Hafler and Howard L. Weiner

    Version of Record online : 28 APR 2006, DOI: 10.1111/j.1600-065X.1987.tb00537.x

  7. Multiple sclerosis: Immune mechanism and update on current therapies

    Annals of Neurology

    Volume 37, Issue S1, May 1995, Pages: 87–101, Shalini Bansil, Dr Stuart D. Cook and Christine Rohowsky-Kochan

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410370710

  8. Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4 + 2H4 +) T Cells in multiple sclerosis

    Annals of Neurology

    Volume 24, Issue 2, August 1988, Pages: 185–191, Michel Chofflon, Howard L. Weiner, Chikao Morimoto and Dr. David A. Hafler

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410240203

  9. Chronic progressive multiple sclerosis: Serial magnetic resonance brain imaging over six months

    Annals of Neurology

    Volume 26, Issue 2, August 1989, Pages: 248–256, R. A. Koopmans, D. K. B. Li, J. J. F. Oger, L. F. Kastrukoff, C. Jardine, L. Costley, S. Hall, E. W. Grochowski and Dr D. W. Paty

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410260211

  10. Effect of Lymphoid Irradiation on Clinical Course, Lymphocyte Count, and T-Cell Subsets in Chronic Progressive Multiple Sclerosis

    Annals of the New York Academy of Sciences

    Volume 540, Issue 1, November 1988, Pages: 533–534, S. D. COOK, C. DEVEREUX, R. TROIANO, C. ROHOWSKY-KOCHAN, G. ZITO and P. C. DOWLING

    Version of Record online : 17 DEC 2006, DOI: 10.1111/j.1749-6632.1988.tb27162.x

  11. Cognitive–linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis

    International Journal of Language & Communication Disorders

    Volume 44, Issue 4, July-August 2009, Pages: 401–420, Catherine Mackenzie and Jan Green

    Version of Record online : 31 DEC 2010, DOI: 10.1080/13682820802697879

  12. Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: a pilot study

    Photodermatology, Photoimmunology & Photomedicine

    Volume 18, Issue 1, February 2002, Pages: 36–41, D. P. Besnier, D. Chabannes, J.-M. G. Mussini, B. Dupas and V. L. M. Esnault

    Version of Record online : 1 MAY 2002, DOI: 10.1034/j.1600-0781.2002.180106.x

  13. Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28− suppressor cell

    Annals of Neurology

    Volume 30, Issue 1, July 1991, Pages: 42–47, Joseph W. Karaszewski, Anthony T. Reder, Banu Anlar, Woo Chan Kim and Dr. Barry G. W. Arnason

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410300109

  14. Decrease of suppressor inducer (cd4+ 2h4+) t cells in multiple sclerosis cerebrospinal fluid

    Annals of Neurology

    Volume 25, Issue 5, May 1989, Pages: 494–499, Michel Chofflon, Howard L. Weiner, Chikao Morimoto and David A. Hafler

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410250512

  15. Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis

    Annals of Neurology

    Volume 37, Issue 1, January 1995, Pages: 30–40, Dr. Donald E. Goodkin, Richard A. Rudick, Sharon Vanderbrug Medendorp, Michele M. Daughtry, Kathleen M. Schwetz, Jill Fischer and Carolyn van Dyke

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410370108

  16. You have free access to this content
    Blood levels of transforming growth factor-beta 1 (TGF-β1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-β1b)

    Clinical & Experimental Immunology

    Volume 113, Issue 1, July 1998, Pages: 96–99, F. Nicoletti, R. Di Marco, F. Patti, E. Reggio, A. Nicoletti, P. Zaccone, F. Stivala, P. L. Meroni and A. Reggio

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2249.1998.00604.x

  17. Benign versus chronic progressive multiple sclerosis: Magnetic resonance imaging features

    Annals of Neurology

    Volume 25, Issue 1, January 1989, Pages: 74–81, R. A. Koopmans, D. K. B. Li, E. Grochowski, P. J. Cutler and Dr. D. W. Paty

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410250112

  18. T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolne

    Acta Neurologica Scandinavica

    Volume 88, Issue 2, August 1993, Pages: 80–86, S. T. F. M. Frequin, K. J. B. Lamers, G. F. Borm, F. Barkhof, P. J. H. Jongen and O. R. Hommes

    Version of Record online : 29 JAN 2009, DOI: 10.1111/j.1600-0404.1993.tb04195.x

  19. Clinical applications of therapeutic apheresis report of the clinical applications committee American society for apheresis

    Journal of Clinical Apheresis

    Volume 3, Issue 1, 1986, Pages: 48–92,

    Version of Record online : 14 NOV 2006, DOI: 10.1002/jca.2920030105

  20. Meta-analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis

    Journal of Clinical Apheresis

    Volume 10, Issue 4, 1995, Pages: 163–170, Eleftherios C. Vamvakas, Alvaro A. Pineda and Brian G. Weinshenker

    Version of Record online : 14 NOV 2006, DOI: 10.1002/jca.2920100402